Funding search · EIN 954296919 · Studio City, CA

International Myeloma Foundation

Name: International Myeloma Foundation grants, 2021–2024
Creator: PaperOrbit
License: https://www.irs.gov/charities-non-profits/exempt-organization-public-disclosure-and-availability-requirements

A grantmaking public charity (files IRS Form 990, Schedule I). Charities like this often run real grant programs with application cycles.

14
grants reported: $410,000
total given: 2021–2024
filing years: $30,000
median grant

Based on grants this organization reported to the IRS for tax years 2021–2024. This is what they filed, not a complete record of their giving, and recent years may be incomplete because filings lag.

Funder website ↗Full IRS filings ↗How this is built Report an error

Funding pattern

What this funder pays for, at what size, and how to position adjacent work. Read from their filings, with every number checked against the record.

Grant history

All 14 reported grants, largest first.

$53,333
New York Weill Cornell Medical Center Fund · New York, NY · 2023
Characterizing the role and targeting of the histone methyltransferase setd2 in multiple myeloma.
$53,333
Case Western Reserve University · Cleveland, OH · 2022
Novel adjuvants to proteasome inhibitors for myeloma therapy
$33,333
National Cancer Institute · New York, NY · 2024
Improving the lives of all people through cancer research
$33,333
The General Hospital Corporation · Boston, MA · 2023
Advancing spinal stability in multiple myeloma: a predictive biomechanical simulation approach.
$33,333
Trustees of Boston University · Boston, MA · 2023
Defining a molecular signature of cardiotoxicity in systemic immunoglobin light chain amyloidosis.
$33,333
Dana Farber Cancer Institute · Boston, MA · 2022
Defining cell states underlying treatment resistance in myeloma by integrating multiomic sequencing data
$33,333
University of San Diego · San Diego, CA · 2021
Tuning the innate immune multiple myeloma microenvironment by modulating irf4
$26,667
New York Weill Cornell Medical Center Fund · New York, NY · 2024
Characterizing the role and targeting of the histone methyltransferase setd2 in multiple myeloma.
$26,667
Case Western Reserve University · Cleveland, OH · 2023
Deciphering the epigenomic mechanisms of transformation from benign monoclonal gammapathies to symptomatic multiple myeloma.
$16,667
The General Hospital Corporation · Boston, MA · 2024
Advancing spinal stability in multiple myeloma: a predictive biomechanical simulation approach.
$16,667
Dana Farber Cancer Institute · Boston, MA · 2023
Tuning the innate immune multiple myeloma microenvironment by modulating irf4
$16,667
Trustees of Boston University · Boston, MA · 2022
Defining a molecular signature of cardiotoxicity in systemic immunoglobin light chain amyloidosis
$16,667
University of San Diego · San Diego, CA · 2022
Tuning the innate immune multiple myeloma microenvironment by modulating irf4
$16,667
Dana Farber Cancer Institute · Boston, MA · 2021
Characterization of rrol-driven lipogenic signaling in multiple myeloma cells.

Grants already paid are the record; PaperOrbit reads your paper and finds the funders whose record matches it — then explains why.

Search funders like this one

Source: IRS Form 990, Schedule I, as filed by this organization. These are grants already paid. Grants paid directly to individuals are reported to the IRS only as totals, so they do not appear as named lines here.